Friday 6 November 2026 Export VXRT’s income statement to Excel — free account

VAXART, INC.

VXRT Healthcare Biotechnology

VAXART, INC.’s revenue for fiscal 2025 (year ended December 2025) was $237.3 million, up 726.7% from fiscal 2024.

Revenue: −85.3%
EPS: −75.0%
Free cash flow: −57.2%

Quarter to September 2026, against a year earlier

0.37 0.03 −7.50%

Follow VXRT

Alert me

Market cap: $92.4M
P/E: 2.8×
Fwd P/E: −2.7×
Dividend yield: —
F-score: 6/9
Altman Z: −1.06
Beneish M: 3.73
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	3.46	3.81	4.07	5.83	+8 more quarters Free account
P/S ratio Full definition →	0.60	0.61	0.57	0.34
P/FCF ratio Full definition →	3.42	4.42	9.92	10.64
P/Operating CF Full definition →	76.35	53.18	(71.47)	2.63
P/B ratio Full definition →	1.65	1.79	1.56	0.92
Price to Tangible BV Full definition →	1.84	1.96	1.69	1.00
EV/Sales Full definition →	0.25	0.35	0.34	0.08
EV/EBITDA Full definition →	0.99	1.87	1.91	0.68
EV/Operating CF Full definition →	1.37	2.50	5.70	2.33
EV/FCF Full definition →	1.41	2.54	5.87	2.37
Quick Ratio Full definition →	1.30	1.52	1.54	1.33
Current Ratio Full definition →	1.71	1.60	1.71	1.57
Net Debt/EBITDA Full definition →	0.00	5.11	(9.77)	(1.12)
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	1.02	1.48	1.51	1.35
Operating CF/Net income Full definition →	(0.08)	(0.21)	(0.40)	0.56
Capex/Depreciation Full definition →	0.00	(0.04)	(0.42)	0.00
Interest Coverage Full definition →	—	(24.48)	10.24	101.51
Research and Development Expense of Revenue Full definition →	214.96%	124.16%	74.98%	43.31%
Selling, General and Administrative Expense of Revenue Full definition →	47.78%	24.29%	11.83%	3.52%
Intangible Assets out of Total Assets Full definition →	0.05	0.04	0.04	0.04
Share Based Compensation of Revenue Full definition →	11.22%	4.75%	3.78%	1.65%
Graham Net Nets Full definition →	0.41	0.23	0.31	0.47
Graham Number Full definition →	0.89	1.11	1.15	0.72
Earnings Yield Full definition →	28.89%	26.23%	24.59%	17.14%
Free Cash Flow Yield Full definition →	29.23%	22.61%	10.08%	9.40%
Revenue per Share Full definition →	0.04	0.11	0.16	0.45
Operating CF per Share Full definition →	0.01	0.01	(0.01)	0.13
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	0.00	0.01	(0.01)	0.13
Cash per Share Full definition →	0.27	0.26	0.25	0.28
Shareholders Equity per Share Full definition →	0.27	0.34	0.39	0.38
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	0.27	0.34	0.39	0.38
Free Cash Flow Full definition →	1.06	2.75	(2.50)	30.66
Working Capital Full definition →	52.50	43.58	54.86	49.37
Capital Expenditures Full definition →	(0.37)	(0.02)	(0.44)	0.00
Net Current Asset Value Full definition →	44.54	33.88	45.77	37.84
EV/EBIT Full definition →	1.49	2.14	2.28	0.99
Capex to Sales Full definition →	0.03	0.00	0.01	0.00
Price to Operating Income Full definition →	3.63	3.73	3.84	4.46
Other line items
Average Receivables Full definition →	58.22	44.03	36.85	31.66
Average Payables Full definition →	41.43	13.79	20.40	14.23
Average Assets Full definition →	178.58	164.64	169.31	176.23
Average Common Equity Full definition →	46.52	57.62	69.87	73.36

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly